Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Clinical trial NCT03384238 · RECRUITING

Trial details

NCT number: NCT03384238
Sponsor: George Poultsides
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma

Start date: 2018-02-07
Primary completion: 2027-03-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.